Osteri Teriparatide Injection I.p., 600 Mcg for To Treat Osteoporosis

Osteri 600 mcg Injection 2.4 ml belongs to the class of medication called 'anabolic (promoting bone formation) agent' indicated for prevention and treatment of osteoporosis in adults and helps to strengthen the bone. This medicine also helps to reduce the risk of spine and hip fractures. Osteoporosis is a medical condition in which bone becomes thin or weak. The chance of developing osteoporosis increases with age, after menopause or by taking corticosteroid medications (such as prednisone) for a long period. If proper treatment is not provided then it can even result in broken bones.
Osteri 600 mcg Injection 2.4 ml contains Teriparatide a synthetic form of the human parathyroid hormone, which helps to regulate calcium metabolism. Osteri 600 mcg Injection 2.4 ml works by causing the body to build new bone by increasing bone strength and bone mass density (BMD) (thickness) and reduce the risk of fractures by stimulating bone formation. It also increases the thickness of bone and rebuilds bones which reduces the risk of spine and hip fractures.